Skip to content

In the BioHarmony Drug Report Database

Lutetium (177lu) oxodotreotide

Lutathera (lutetium dotatate lu-177) is an unknown pharmaceutical. Lutetium dotatate lu-177 was first approved as Lutathera on 2018-01-26. Lutathera's patent is valid until 2038-07-25 (FDA).
Trade Name Lutathera
Common Name Lutetium (177lu) oxodotreotide
Indication
Drug Class Antineoplastic agent
Lutetium (177lu) oxodotreotide
Get full access now